Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWalker Crips Regulatory News (WCW)

  • This share is currently suspended. It was suspended at a price of 13.50
  • There is currently no data for WCW

Board and Management Changes

9 Jul 2025 13:15

RNS Number : 4003Q
Walker Crips Group plc
09 July 2025
 

9 July 2025

 

Walker Crips Group plc

("Walker Crips" or the "Company")

 

Board and Management Changes

 

Walker Crips Group PLC is pleased to announce a number of changes to the composition of its Board of Directors (the "Board") and executive leadership team as part of a strategic reorganisation to support the Company's growth and operational resilience.

 

As previously announced, Jo Welman was appointed as Non-Executive Chair on 31 March 2025, and Linus Lim and Mark Nelligan joined the Board as Non-Executive Directors on 6 February and 25 April 2025 respectively.

 

Following a comprehensive review of the Company's senior leadership structure, the Company will implement a joint leadership model with the appointment of two Joint Chief Executive Officers. Both appointments will be Executive Directors of the Company and members of the Board.

 

Christian Dougal, currently Chief Risk and Compliance Officer, will be appointed Joint CEO, responsible for the Company's administrative functions, including Finance, HR, Risk & Compliance, and IT Support. Christian joined the Company in July 2024, and his leadership has been instrumental in addressing the Company's regulatory priorities.

 

Sean Lam, who currently serves as CEO, will assume the title of Joint CEO and will continue to oversee the Company's commercial operations. He will retain his role as CEO of Walker Crips Investment Management ("WCIM").

 

 

Walker Crips confirms that there are no details that require disclosure under UK Listing Rule 6.4.8R in respect of Christian Dougal.

 

Jo Welman, Chair of Walker Crips, commented:

 

"These changes mark a critical step in building a leadership platform that reflects the scale and ambition of our strategy. Christian brings operational discipline and regulatory depth, while Sean's commercial instincts and leadership continuity will be invaluable as we pursue our growth objectives. I would also like to thank the entire leadership team for their commitment to positioning the Company for long-term success."

 

For further information, please contact:

 

Walker Crips Group plc

Craig Harrison, Media Relations

Tel: +44 (0)20 3100 8000

Singer Capital Markets

Charles Leigh-Pemberton / Asha Chotai

Tel: +44 (0)20 7496 3000

 

 

Further information on Walker Crips Group is available on the Company's website: www.walkercrips.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABBGDRCUGDGUC
Date   Source Headline
1st Jun 20169:59 amRNSHolding(s) in Company
25th May 20164:25 pmRNSDirector/PDMR Shareholding
10th May 20165:09 pmRNSHolding(s) in Company
9th May 20164:25 pmRNSDirector/PDMR Shareholding
21st Apr 20162:00 pmRNSReplacement: Issue of Equity
21st Apr 20167:00 amRNSIssue of Equity
24th Mar 20163:46 pmRNSDirector/PDMR Shareholding
7th Mar 20163:49 pmRNSDirector/PDMR Shareholding
25th Feb 201610:31 amRNSDirector/PDMR Shareholding
2nd Feb 20162:35 pmRNSDirector/PDMR Shareholding
27th Jan 20163:14 pmRNSIssue of Equity and Total Voting Rights
22nd Jan 20163:23 pmRNSDirector/PDMR Shareholding
18th Dec 20154:27 pmRNSDirector/PDMR Shareholding
15th Dec 20157:00 amRNSDirector/PDMR Shareholding
3rd Dec 20157:00 amRNSIssue of Equity and Total Voting Rights
24th Nov 20155:15 pmRNSDirector/PDMR Shareholding
19th Nov 20157:00 amRNSResults for the six months ended 30 September 2015
29th Oct 20156:23 pmRNSDirector/PDMR Shareholding
15th Oct 20153:45 pmRNSBlocklisting Interim Review
25th Sep 20154:50 pmRNSDirector/PDMR Shareholding
14th Aug 20152:07 pmRNSDirector/PDMR Shareholding
3rd Aug 20152:32 pmRNSResults of AGM
24th Jul 20154:12 pmRNSDirector/PDMR Shareholding
16th Jul 201511:15 amRNSHolding(s) in Company
26th Jun 20152:54 pmRNSDirector/PDMR Shareholding
25th Jun 20157:00 amRNSFinal Results - Continued growth in core business
1st Jun 201511:08 amRNSHolding(s) in Company
26th May 20152:56 pmRNSDirector/PDMR Shareholding
19th May 20155:42 pmRNSHolding(s) in Company
27th Apr 20154:13 pmRNSDirector/PDMR Shareholding
24th Apr 20155:11 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
22nd Apr 201511:20 amRNSBlocklisting Interim Review
22nd Apr 20157:00 amRNSDirector/PDMR Shareholding
30th Mar 201511:41 amRNSIssue of Equity and Total Voting Rights
30th Mar 20157:00 amRNSDirector/PDMR Shareholding
25th Mar 20152:20 pmRNSHolding(s) in Company
24th Mar 20155:05 pmRNSDirector/PDMR Shareholding
10th Mar 20157:02 amRNSAdmission of Consideration Shares
9th Mar 20157:00 amRNSAcquisition of Barker Poland Asset Management LLP
25th Feb 20157:02 amRNSDirector/PDMR Shareholding
24th Feb 20151:40 pmRNSHolding(s) in Company
23rd Jan 20154:27 pmRNSDirector/PDMR Shareholding
30th Dec 20149:08 amRNSDirector/PDMR Shareholding
22nd Dec 20149:09 amRNSDirector/PDMR Shareholding
20th Nov 20144:24 pmRNSDirector/PDMR Shareholding
20th Nov 20147:00 amRNSInterim Management Statement
24th Oct 20143:09 pmRNSDirector/PDMR Shareholding
14th Oct 201410:47 amRNSBlocklisting Interim Review
29th Sep 201412:39 pmRNSDirector/PDMR Shareholding
14th Aug 20146:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.